Corcept Therapeutics's total assets for Q4 2024 were $840.55M, an increase of 7.18% from the previous quarter. CORT total liabilities were $160.96M for the fiscal quarter, a 10.69% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.